Emily DiMango M.D.

Professor of Medicine at Columbia University Medical Center
Director, John Edsall-John Wood Asthma Center
Director, Adult Cystic Fibrosis Program


Education and Training

B.S. at New York University, summa cum laude, New York, New York, 1984
Medical School:
New York University School of Medicine, New York, New York, 1989
Internal Medicine, NewYork-Presbyterian/Columbia University Medical Center, New York, New York, 1989-1990
Internal Medicine, NewYork-Presbyterian/Columbia University Medical Center, New York, New York, 1990-1992
Pulmonary Division, NewYork-Presbyterian/Columbia University Medical Center, New York, New York, 1992-1996

Honors and Awards

  • 1984 Phi Beta Kappa, New York University, New York, New York
  • 1984 Brown Award for excellence in Chemistry, New York University
  • 1993 Teaching Award in Pulmonary Medicine
  • 1994-1996 J. Amberson Burns Fellow of American Lung Association


For appointments: 

Contact: Ida Soler Cruz
622 W. 168th Street
PH 8-Center
New York, NY 10032
P: (212) 305-0631
F: (212) 342-4784


  • Pulmonary Disease Medicine

Clinical Expertise

  • Adult cystic fibrosis
  • Bronchiectasis
  • Asthma

Clinical Centers

Board Certifications

  • Internal Medicine Diplomate, 1992, 2006
  • Pulmonary Disease Diplomate, 1994, 2005, 2015


Contact Information: 

E.DiMango Laboratory

Research Interests

  • Adult CF
  • Bronchiectasis
  • Asthma

Selected Publications

  1. Riquelme SA, Hopkins BD, Wolfe AL, DiMango E, Kitur K, Parsons R, Prince A. Cystic Fibrosis Transmembrane Conductance Regulator Attaches tumor suppressor PTEN to the member and promotes anti Pseudomonas aeruginosa immunity. Immunity 2017 Dec 19; 47 (6): 1169-81. PMID 29246444.
  2. Rogers L, Sugar EA, Blake K, Castro M, Dimango E, Hanania NA, Happel KI, Peters SP, Reibman J, Saams J, Teague WG, Wise RA, Holbrook JT; American Lung Association Airways Clinical Research Centers. Step-down therapy for asthma well controlled on inhaled corticosteroid and long acting beta-agonist: a randomized clinical trial. J Allergy Clin Immunol Pract. 2018 March-Apr 6 (2): 633-643. PMID 28974349.
  3. Cahill KN, Katz HR, Cui J, Lai J, Kazani S, Crosby-Thompson A, Garofalo D, Castro M, Jarjour N, DiMango E, Erzurum S, Trevor JL, Shenoy K, Chinchilli VM, Wechsler ME, Laidlaw TM, Boyce JA, Israel E.KIT Inhibition by imatinib in patients with severe refractory asthma. N Engl J Med. 2017 May 18;376(20):1911-1920. PMID: 28514613.
  4. Keating C, Poor AD, Liu X, Chiuzan C, Backenroth D, Zhang Y, DiMango E. Reduced survival in adult cystic fibrosis despite attenuated lung function decline. J Cyst Fibros 2016 Aug: S1569-1973. PMID: 27522311.
  5. Slankard M, Michelis MA, Mansukhani M, McGoey B, Paige A, Andrews H, Lederer D, Canfield S, DiMango, E. Impact of the Arg 16 allele of the B2AR gene on the effect of withdrawal of LABA in patients with moderate to severe asthma. J Asthma 2016 Apr 6:1-7.
  6. DiMango E, Serebrisky D, Narula S, Shim C, Keating C, Sheares B, Perzanowski M, Miller R, DiMango A, Andrews H, Merle D, Liu X, Calatroni A, Kattan M. Individualized Household Allergen intervention lowers allergen level but not asthma medication use: a randomized controlled trial. J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):671-679.e4. PMID: 27025297.
  7. Quezada W, Kwak ES, Reibman J, Rogers L, Mastronarde J, Teague WG, Wei C, Holbrook JT, DiMango E. Predictors of asthma exacerbation among patients with poorly controlled asthma despite inhaled corticosteroid treatment. Ann Allergy Asthma Immunol. 2015 Dec 19. S1081-1206(15)00798-X. doi: 10.1016/j.anai.2015.11.011. PMID: 26712474.
  8. Robinson N, DiMango E. Prevalance of gastroesophageal reflux in cystic fibrosis and implications for lung disease. Annals of the American Thoracic Society, 2014 Jul; 11 (6): 964-8. PMID 24964289.
  9. Lovinsky-Desir S, Ridder R, Torrone D, Maher C, Narula S, Scheuerman M, Merle D, Kattan M, DiMango E, Miller RL. DNA methylation of the allergy regulatory gene interferon gamma varies by age, sex and tissue type in asthmatics. Clin Epigenetics. 2014 May 22: 6 (1): 9. PMID 24891923.
  10. DiMango, E, Walker, Keating, Berdella, M, Robinson N, Langerfelder-Schwind, Levy D, Liu X. Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis. Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis. BMC Pulm Med. 2014 Feb 15;14:21. PMID 24528942.
  11. DiMango, E, Holbrook, J, Simpson, Reibman, J, Richter, J, Mastronarde, J, Wise, R for the American Lung Association Asthma Clinical Research Centers. Effects of Asymptomatic Proximal and Distal Gastroesophageal Reflux on asthma severity. AJRCCM 2009 Nov 1;180(9):809-16.

View Dr. DiMango's full list of publications from PubMed